Company profile

Amal Therapeutics SA

Amal Therapeutics SA, a spin-off from the University of Geneva, is developing new cancer vaccines, using with a proprietary family of vectors.

Amal Therapeutics SA

Source: startup.ch

Highlights

Top 100 Swiss Startup Award 2017Top 100 Swiss Startup Award 2017 Top 100 Swiss Startup Award 2016Top 100 Swiss Startup Award 2016 Top 100 Swiss Startup Award 2015Top 100 Swiss Startup Award 2015 Top 100 Swiss Startup Award 2014Top 100 Swiss Startup Award 2014 Winner Venture KickWinner Venture Kick Innosuisse CertificateInnosuisse Certificate

More news about Amal Therapeutics SA

28.06.2022 09:00

Three startups in the spotlight
  • Award
    Please login or
    register to use the
    awards follow feature
    25.09.2020 11:30

    Recognition for Swiss innovation
  • Award
    Please login or
    register to use the
    awards follow feature
    03.08.2020 11:18

    Female entrepreneurs in the spotlight
  • Award
    Please login or
    register to use the
    awards follow feature
    16.07.2019 09:15

    Amal Therapeutics becomes a subsidiary of a German Pharma giant
  • Background
  • Financing
    Please login or
    register to use the
    awards follow feature
    03.05.2019 15:01

    AMAL Therapeutics enters clinical collaboration with Boehringer Ingelheim
  • Success
    Please login or
    register to use the
    awards follow feature
    12.11.2018 10:05

    AMAL Therapeutics finalises CHF 33 million Series B round

  • Financing
    Please login or
    register to use the
    awards follow feature
    05.09.2017 11:45

    AMAL Therapeutics raises CHF 8.8 million in Series B round
  • Financing
  • Success
    Please login or
    register to use the
    awards follow feature
    14.09.2016 21:17

    Top 100 Swiss startups have been revealed
  • Award
    Please login or
    register to use the
    awards follow feature
    30.03.2016 09:24

    Amal Therapeutics raises CHF 3 million in a Series A financing round
  • Financing
    Please login or
    register to use the
    awards follow feature
    24.03.2016 08:10

    Amal Therapeutics receives CTI grant
  • Support
    Please login or
    register to use the
    awards follow feature
    06.11.2015 13:42

    11 start-ups selected for Swiss Venture Day Romandie
  • Financing
  • Support
    Please login or
    register to use the
    awards follow feature
    15.09.2015 16:12

    Amal Therapeutics and Oslo University Hospital announce research collaboration
  • Expansion
    Please login or
    register to use the
    awards follow feature
    28.08.2015 14:50

    Start-ups selected for the 50th Swiss Venture Day
  • Financing
    Please login or
    register to use the
    awards follow feature
    29.06.2015 16:36

    Amal achieves proof of concept
  • Success
    Please login or
    register to use the
    awards follow feature
    17.04.2015 11:52

    Nine hot start-ups, 400 visitors and Joe Jimenez
  • Support
    Please login or
    register to use the
    awards follow feature
    24.07.2014 14:09

    € 1.07 million grant to Amal Therapeutics and TransCure bioServices
  • Award
  • Support
    Please login or
    register to use the
    awards follow feature
    09.07.2014 15:32

    Amal Therapeutics SA announces appointment of Johanna Holldack as Chairman
    Please login or
    register to use the
    awards follow feature
    25.03.2014 16:05

    Amal Therapeutics, un exemple de recherche de Seed financing dans le domaine biotech
  • Support
    Please login or
    register to use the
    awards follow feature
    20.02.2014 15:28

    Amal Therapeutics SA raises seed round from Boehringer Ingelheim Venture Fund and High-Tech Gründerfonds
    Please login or
    register to use the
    awards follow feature
    Amal Therapeutics SA

    Founded
    2012

    Kanton
    GE

    Homepage

    rss